BRIEF published on 07/15/2026 at 13:10, 3 months 11 days ago Septa Pharmaceuticals Acquires CeeNU® from Bristol Myers Squibb Strategic Partnerships Septa Pharmaceuticals CeeNU® Acquisition Oncology Expansion Healthcare Supply
PRESS RELEASE published on 07/15/2026 at 13:05, 3 months 11 days ago Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada Septa Pharmaceuticals Inc. successfully acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada, reinforcing its specialty oncology pharmaceutical portfolio and commitment to patient care Acquisition Pharmaceutical Oncology Septa Pharmaceuticals Inc. CeeNU®
Published on 10/27/2026 at 00:10, 54 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:30, 1 hour 34 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:00, 2 hours 4 minutes ago American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 3 hours 4 minutes ago IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/26/2026 at 22:00, 3 hours 4 minutes ago Alset AI Announces Non-Brokered Private Placement Offering of a Minimum of $650,000 and a Maximum of $800,000
Published on 10/26/2026 at 22:23, 2 hours 41 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 3 hours 6 minutes ago EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 3 hours 31 minutes ago UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT
Published on 10/26/2026 at 20:00, 5 hours 4 minutes ago EQS-Adhoc: Hypoport SE: Gross profit growth and increase in EBIT in Q1-Q3 2026
Published on 10/26/2026 at 19:10, 5 hours 54 minutes ago PolyPeptide announces results of the extraordinary general meeting of shareholders
Published on 10/26/2026 at 18:11, 6 hours 53 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 17:30, 7 hours 34 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
Published on 10/26/2026 at 07:30, 17 hours 34 minutes ago EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 3 days 4 hours ago Disclosure of transactions in own shares from October 19 to October 23, 2026
